The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice

Random-Effects Models for Longitudinal Data

Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208

Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174

Genome-wide association study reveals genetic risk underlying Parkinson's disease

Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489

Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037

Targeted tau protein degradation: a promising therapeutic approach for tauopathies

Baazaoui, N., Alfaifi, M. Y., Shati, A. A., Saad, R. B., & Garzoli, S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.041 · Cited by 5

Tau and Alzheimer’s Disease: Molecular Mechanisms and Treatment Approaches

Reiss, A. B., Muhieddine, D., Leon, A. Z. D., Voloshyna, I., Gomolin, I. H., & Pinkhasov, A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01092-y · Cited by 4

Noninvasive Detection of Oxidative Stress in a Mouse Model of 4R Tauopathy via Positron Emission Tomography with [18F]ROStrace

Gallagher, E. P., Li, S., Lee, H. S., Xu, H. W., LEE, V. M. ‐., Mach, R. H., & McManus, M. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051845 · Cited by 4

Broader implications: biological and clinical significance of microtubule acetylation

Kelley, T. J., & Rymut, S. M. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s77040 · Cited by 4

The Role of Natural Products in Drug Discovery

Haustedt, L. O., & Siems, K. (2015) · Wiley eBooks · doi:10.1002/9781118771723.ch14 · Cited by 4

Post-traumatic stress disorder: pathogenesis, epidemiological characteristics, animal models, and potential therapeutic strategies

Nguyen, F., & Shetty, A. K. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100005 · Cited by 4

Comprehending Alzheimer's Disease: Molecular Mechanisms and Treatment Strategies

Rathee, S., Pandey, V., Soni, S., Sen, D., & Jain, S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050368798250626075628 · Cited by 6

Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation

Juanes, A. M., Vogels, T., Hertog, S. K.-D., Loos, M., Lütjohann, D., Giera, M. A., & van der Kant, R. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100952 · Cited by 3

Molecular Pathways in Alzheimer’s Disease and Cognitive Function

Chen, X., Reichert, M. C., & Gan, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00005-x · Cited by 3

Manganese-enhanced magnetic resonance imaging method detects age-related impairments in axonal transport in mice and attenuation of the impairments by a microtubule-stabilizing compound

Terry, A. V., Beck, W. D., Lin, P., Callahan, P. M., Rudic, R. D., & Hamrick, M. W. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147947 · Cited by 3

Immunotherapeutics for AD: A Work in Progress

Sharma, A., Anand, J. S., & Kumar, Y. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210903101522 · Cited by 3

Toward magnetic resonance imaging biomarkers for progressive supranuclear palsy and multisystem atrophy

Sauvaget, F., & Litvan, I. (2012) · Movement Disorders · doi:10.1002/mds.25196 · Cited by 3

Therapeutic Potential of Traditional Oriental Medicines in Targeting Tau Pathology: Insights from Cell-free and Cell-based Screening

Park, H. H., Kim, B., Leem, S. H., Park, Y. H., Chung, H., Yoo, D., Park, I., Nam, Y., Kim, S., Shin, S. J., et al. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673295901240311072440 · Cited by 2

Bi-allelic variants in WDR47 cause a complex neurodevelopmental syndrome

Bayam, E., Tilly, P., Collins, S. C., Rivera Alvarez, J., Kannan, M., Tonneau, L., Brivio, E., Rinaldi, B., Lecat, R., Schwaller, N., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00178-z · Cited by 2

Mechanical stimulation prevents impairment of axon growth and overcompensates microtubule destabilization in cellular models of Alzheimer’s disease and related Tau pathologies

Galeotti, A. A., Santucci, L., Klimek, J., Kabbani, M. A. A., Zempel, H., & Raffa, V. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1519628 · Cited by 2

Imaging microtubule dynamics: A new frontier in biomarker development for neurodegenerative diseases

Damuka, N., Lockhart, S. N., & Sai, K. K. S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70670 · Cited by 4

White matter degeneration precedes tau aggregation in rats with Alzheimer's-like tauopathy

Ai, L., Carmo, S. D., Antel, J. P., Kuhlmann, T., & Cuello, A. C. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107149 · Cited by 2

Cevipabulin induced abnormal tubulin protofilaments polymerization by binding to Vinblastine site and The Seventh site

Bai, P., Yan, W., & Yang, J. (2023) · Cytoskeleton · doi:10.1002/cm.21813 · Cited by 2

The emerging nontraditional roles for tau in the brain

Tseng, J., & Cohen, T. J. (2023) · Cytoskeleton · doi:10.1002/cm.21811 · Cited by 2

A novel tauopathy model mimicking molecular and spatial aspects of human tau pathology

Yanai, R., Mitani, T. T., Susaki, E. A., Minamihisamatsu, T., Shimojo, M., Saito, Y., Mizuma, H., Nitta, N., Kaneda, D., Hashizume, Y., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae326 · Cited by 2

APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model

Vanherle, S., Janssen, A., de Ravé, M. G., Janssen, B., Lodder, C., Lucena, P. B., Kessels, S., Hardy, J., Vandeput, E., Wang, Y., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03036-7 · Cited by 4

Re-mention of an old neurodegenerative disease: Alzheimer’s disease

Zhang, P., Adams, U., & Yuan, Z. (2013) · Chinese Science Bulletin · doi:10.1007/s11434-013-5673-x · Cited by 2

Therapeutic Links between Alzheimer’s Disease and Brain Cancer: Drug Discovery Consequences

Kraus, J. (2013) · ChemMedChem · doi:10.1002/cmdc.201300006 · Cited by 2

Chemical Modulators of Protein Misfolding, Neurodegeneration and Tau

Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801944-3.00001-1 · Cited by 2

Implications of statin metabolism related gene testing in guiding individualized drug use in cardiovascular diseases

Zhang, Y., You, X., Ren, Y., & Cui, J. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v22i2.30 · Cited by 2

Frontotemporal lobar degeneration

Kim, B., Viera-Ortiz, A., Phan, J. M., Irwin, D. J., & Lee, E. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00041-1 · Cited by 3

Excitotoxicity and Axon Degeneration

King, A. E., & Vickers, J. C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_145 · Cited by 2

Microtubule Stabilization

Ballatore, C., Smith, A. B., Lee, V. M.-Y., Trojanowski, J. Q., & Brunden, K. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00011-3 · Cited by 2

Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy

Vasconcelos, B., Bird, M., Stancu, I., Terwel, D., & Dewachter, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00006-3 · Cited by 2

DCP-LA, a New Strategy for Alzheimer's Disease Therapy

Nishizaki, T. (2017) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2017/9.1159 · Cited by 2

Drug Discovery from Medicinal Plants against Alzheimer's Disease

Marzouk, M. M., Farid, M. M., Hegazi, N. M., & Ezzat, S. M. (2023) · Wiley eBooks · doi:10.1002/9781119794127.ch3 · Cited by 4

Tau-Centric Therapies for Treating Alzheimer’s Disease

Quraishe, S., Cowan, C. M., & Mudher, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00005-3 · Cited by 1

Reshaping cytoskeleton: different acts of modulatory compounds

Zobaroğlu-Özer, P., & Bora, G. (2020) · Istanbul Journal of Pharmacy · doi:10.26650/istanbuljpharm.2020.0015 · Cited by 1

The Central Role of Actin in Creutzfeldt-Jakob Disease: Unlocking Therapeutic Pathways

Bastar-Juarez, L., Castillo-Estrada, X., Margarit-Mendez, D., & Coca-Gutierrez, P. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05112-z · Cited by 1

Circadian timing and entrainment properties of the SCN pacemaker in the PS19 mouse model of tau pathology

Halloy, N. R., Formanowicz, M., Pham, N. N. L., Hoyt, K. R., & Obrietan, K. H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115458 · Cited by 1

The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's disease

Nixon, A. G., Hong, N. S., Agha, B. M., Ham, J. R., Monteith, M., Kaloa, T., Kyriazopolus, A., Nielsen, M., Robertson, D. R., Golubov, A., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261421654 · Cited by 1

Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease

Skrehot, J. T., & Kurouski, D. (2026) · Protein Science · doi:10.1002/pro.70635 · Cited by 2

Targeting microtubules in axonal re‐ and degeneration (Commentary on Li et al. ())

Brandt, R. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13615 · Cited by 1

Investigación y terapias en la enfermedad de Alzheimer basadas en beta amiloide y tau

López-Camacho, P. Y., Guzmán-Hernández, R. N.-H., Gonzalez, V. H. H., Muñoz, J. E. D., García‐Sierra, F., & Basurto‐Islas, G. (2017) · Archivos de Neurociencias · doi:10.31157/an.v22i2.154 · Cited by 1

Inhibitors of Mitotic Kinesins for Cancer Treatment: Consequences for Neurons

Kahn, O. I., & Baas, P. W. (2015) · Springer eBooks · doi:10.1007/978-94-017-9732-0_14 · Cited by 1

Synthesis of stable isotope‐labeled epothilone D using a degradation–reconstruction approach

Burrell, R. C., Turley, W. A., & Bonacorsi, S. J. (2015) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3312 · Cited by 1

Experimental Models of Tau Aggregation

Buck, K., Jahn, T. R., & Gasparini, L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00070-1 · Cited by 1

Efficacy of epothilones in central nervous system trauma treatment: what has age got to do with it?

Blizzard, C. A., Clark, J. A., Zhu, Z., Chuckowree, J. A., & Dickson, T. C. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295312 · Cited by 1

The Role of Polyphenols in the Treatment of Alzheimer's Disease: Narrative Review

Alattiya, R. H., Tarish, F. K., Hashim, L. L., & Hussain, S. A. (2021) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v1i.31 · Cited by 1

Epothilone D – correct drug, wrong disease

Ke, Y. D., & Ittner, L. M. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12478 · Cited by 1

The IDH-Tau-EGFR triad defines diffuse glioma pathology by controlling mesenchymal differentiation and neo-vascular fitnessPreprint

Gargini, R., Segura-Collar, B., Hernández-SanMiguel, E., Garcia-Escudero, V., Romero-Bravo, A., Herránz, B., Núñez, F. J., García-Pérez, D., Ayuso-Sacido, A., Seoane, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/541326 · Cited by 2

Novel Therapeutic Targets and Biomarkers for the Treatment of Progressive Supranuclear PalsyPreprint

Tyer, I., & Hill, A. (2020) · Preprints.org · doi:10.20944/preprints202006.0147.v1 · Cited by 1

Neuroprotective role of Hippo signaling by microtubule stability control in Caenorhabditis elegans

Lee, H., Kang, J., Lee, S., Lee, D., Chung, C. H., & Lee, J. (2024) · eLife · doi:10.1101/2024.03.11.584363 · Cited by 1

Recent Update of Clinical Drug Trials in Alzheimer’s Disease

Kang, H., & Park, K. W. (2015) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2015.4.2

Tau Pathology: A Selected View on the Current Status

Gozes, I. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5866-7_5

Regulation of the kinesin-3 motor, KIF1A, in a cellular model of Alzheimer’s disease

Akram, A. (2016) · Summit (Simon Fraser University)

Cytoskeleton and CRMPs in Neuronal Morphogenesis and Neurological Diseases: Potential Targets for New Therapies

Quach, T., & Auvergnon, N. (2016) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000257

Bioanalytical approach to the interaction of novel sym-triazine derivatives with Alzheimer's disease biomarkers

Liu, A. W. K. (2015) · TSpace (University of Toronto)

Nanoparticle Based siRNA Delivery to the Central Nervous System: A Potential Therapeutic Approach

Shyam, R. (2015)

Potential Treatments for Alzheimer’s Disease

Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00008-2 · Cited by 1

A New Diagnostic Paradigm

Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00006-9

Potential Neuroprotective Strategies for Concussion and Chronic Traumatic Encephalopathy

Farooqui, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813596-9.00009-2

What’s New in the War on Alzheimer Disease?

Woods, A. G. (2014)

Studies toward the Total Synthesis of Epothilone D: Synthesis of the Thiazole-Containing Northern Segment

Suzuki, M., Hashimoto, S., Sakamoto, S., Kogen, H., & Kobayashi, K. (2019) · Natural Product Communications · doi:10.1177/1934578x19868597

Docking molecular, síntese e estudo biológico de potenciais inibidores da beta-secretase (BACE-1) e da acetilcolinesterase (AChE)

Sakata, R. P. (2018) · doi:10.47749/t/unicamp.2018.1059514

Neuronal structure in aging

Cartelli, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818000-6.00006-8

Investigating the Role of Mechanical Properties in Biological Systems

Shamitko-Klingensmith, N. M. (2014) · doi:10.33915/etd.6613

Studies on Relationship between a Microtubule-associated Protein Tau and Alzheimer's Disease Progression and Drug Discovery Targeting Tau

大西, 智., & Onishi, T. (2016) · Terrestrial Environment Research Center (University of Tsukuba)

Kif11 overexpression rescues cognition, long-term potentiation, and spine defects in mouse and cell models of Alzheimer’s diseasePreprint

Lucero, E., Freund, R. K., Johnson, N. R., Dooling, B. R., Sullivan, E. M., Prikhodko, O., Ahmed, M. M., Dell’Acqua, M. L., Chial, H. J., & Potter, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.09.459627

Síntese e avaliação da citotoxicidade de chalconas e derivados com efeito inibitório sobre acetilcolinesterase e beta-secretase (BACE-1)ß

Antoniolli, G. (2018) · doi:10.47749/t/unicamp.2018.1126989

Increased Expression of KIF11/Kinesin5 Offsets Alzheimer Aβ-Mediated Toxicity and Cognitive Dysfunction in Cell Culture, Mice, and HumansPreprint

Lucero, E., Freund, R. K., Smith, A. N., Johnson, N., Dooling, B. R., Sullivan, E. M., Prikhodko, O., Ahmed, M. M., Bennett, D. A., Hohman, T. J., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4050072

Cellular Mechanisms of Dementia

Gan, L. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0054

Axonal Transport and Neurodegenerative Diseases☆

Roy, S., Irwin, D. J., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04517-7

Emerging Therapeutic Approaches for Neurodegenerative Diseases

Ugale, R. R., & Sarode, L. P. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010013

Nove terapije u liječenju Alzheimerove bolesti

Perković, R., Tomić, S., Jurić, S., Gudelj, E., & Hrvoić, L. (2023) · Medicina Fluminensis · doi:10.21860/medflum2023_292445

Research Progress of Chemical Synthesis Drugs and Biotechnology Drugs for Alzheimer’s Disease

陈, 学. (2024) · Open Journal of Natural Science · doi:10.12677/ojns.2024.122051

Effects of Epothilone D on Social Defeat Stress-induced Changes in Microtubule-related and Endoplasmic Reticulum Stress Protein Expression

Le, T.-H., Li, L., Rami, F. Z., Oh, J.-M., Chun, S., & Chung, Y. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1212

Treatment strategies used for Alzheimer's disease

Kar, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00007-0

Neuroprotective role of Hippo signaling by microtubule stability control in C. elegansPreprint

Lee, H., Kang, J., Lee, S., Lee, D., Chung, C. H., & Lee, J. (2024) · eLife · doi:10.7554/elife.102001.1

Neuroprotective role of Hippo signaling by microtubule stability control in C. elegansPreprint

Lee, H., Kang, J., Lee, S., Lee, D., Chung, C. H., & Lee, J. (2025) · eLife · doi:10.7554/elife.102001.2

Protein kinase CK2α′ as a dual modulator of neuroimmune signaling and synaptic dysfunction in tauopathy

White, A., Gavrilyuk, P., Gu, P., Moya, R. F., Thurston, R. H., Fickak, A., Rozema, N. B., Keshavaram, P., Vermilyea, S., Schlichte, R., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00563-3

Additional file 5 of Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice

Yang, T., Liu, H., Tran, K. C., Leng, A., Massa, S. M., & Longo, F. M. (2020) · Figshare · doi:10.6084/m9.figshare.12923390

Additional file 1 of Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy

Brody, A. H., Nies, S. H., Guan, F., Smith, L. M., Mukherjee, B., Salazar, S. A., Lee, S., Lam, T. K. T., & Strittmatter, S. M. (2022) · Figshare · doi:10.6084/m9.figshare.19695711

Additional file 1 of Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model

Damuka, N., Orr, M. E., Bansode, A. H., Krizan, I. M., Miller, M. D., Lee, J., Macauley, S. L., Whitlow, C. T., Mintz, A., Craft, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20381869

Additional file 4 of Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice

Yang, T., Liu, H., Tran, K. C., Leng, A., Massa, S. M., & Longo, F. M. (2020) · Figshare · doi:10.6084/m9.figshare.12923387

Additional file 2 of Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice

Yang, T., Liu, H., Tran, K. C., Leng, A., Massa, S. M., & Longo, F. M. (2020) · Figshare · doi:10.6084/m9.figshare.12923381

Additional file 3 of Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice

Yang, T., Liu, H., Tran, K. C., Leng, A., Massa, S. M., & Longo, F. M. (2020) · Figshare · doi:10.6084/m9.figshare.12923384

Additional file 1 of Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice

Yang, T., Liu, H., Tran, K. C., Leng, A., Massa, S. M., & Longo, F. M. (2020) · Figshare · doi:10.6084/m9.figshare.12923378

Efficacy and Safety of Tau-Targeting Therapies in Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Trials

Wang, H., & Yao, Z. (2025) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0026

Emerging therapeutics and future insights into the pathobiology of Alzheimer’s disease

Ullah, S.-K. L. I. (2018) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/12.2.231-246

Mécanismes de stabilisation des microtubules : rôle du nucléotide lié à la tubuline et action des protéines associées aux microtubules

Bagdadi, N. (2021) · theses.fr (ABES) · doi:10.70675/f5dafa48z046bz4f81z92e6zb415fb85d4f3

Cytoskeleton-mediated autophagy regulation in neuroimmune contexts: molecular mechanisms and functional perspectives

Cao, X., Zhang, H., & Wang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1732775

FKBP51 inhibition by SAFit2 modulates tau pathology and cognitive deficits in PS19 mice

Contreras-Marciales, A., Mezquite-Garcia, D., Verdina, L. A., Elnahrawy, A., Wolf, T., Guergues, J., Parikh, P., Hunter, E. R., Acosta, D. H., Stevens, S. M., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02107-3

Tubulin State Determines Proteopathic Fate

Lucas, L., Quan, M. D., Ferreon, J. C., & Ferreon, A. C. M. (2026) · Cytoskeleton · doi:10.1002/cm.70162

Genetic suppressions of CRMP2 phosphorylation ameliorate α-synuclein accumulation in an α-synucleinopathy mouse model

Guevara, V. A., Goshima, Y., & Ohshima, T. (2026) · Neuroscience Letters · doi:10.1016/j.neulet.2026.138661

Diagnosis and management of frontotemporal dementia: a narrative review.

Cenacchi, V., Lombardo, T., Palacino, F., Cattaruzza, T., Manganotti, P., & Benussi, A. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2687481

Dominant α-tubulin mutations rescue tauopathy neurodegenerative phenotypes in C. elegansPreprint

Benbow, S. J., Saxton, A. D., Baum, M., Uhrich, R. L., Stair, J. G., Keene, K., Dahleen, C., Wordeman, L. G., Liachko, N. F., Kow, R. L., et al. (2026) · eLife · doi:10.7554/elife.111266

Dominant α-tubulin mutations rescue tauopathy neurodegenerative phenotypes in C. elegansPreprint

Benbow, S. J., Saxton, A. D., Baum, M., Uhrich, R. L., Stair, J. G., Keene, K., Dahleen, C., Wordeman, L. G., Liachko, N. F., Kow, R. L., et al. (2026) · eLife · doi:10.7554/elife.111266.1

Tau physiology and pathology: impacts on cellular structures and neurodegenerative diseases

Akbari, V., & Bahramikia, S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02328-w

THERAPY FOR ALZHEIMER’S DISEASE - FOCUS ON LECANEMAB

Jońca, M., Majchrowicz, G., Kurys, N., Piekarska, W., Litke, S., & Gołacka, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.5795

Transient entanglement in minimal open XXZ spin chains: a toy-model analogy for microtubule-inspired quantum biology

Cheung, N. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1855963

Gene therapy in Alzheimer’s disease (AD)

Bemanalizadeh, M., Ashrafi, M., Eslami, M., Moein, S., Kazemi, A., & Mansouri, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00014-2

Home-administered unfocused transcranial ultrasound in subjective cognitive decline and dementia: an open-label, uncontrolled feasibility pilot study

Wahbeh, H., Cooley, S., Chamberlin, S. R., Brophy, T., & Hameroff, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1937897

When the Cytoskeleton Fails: Primary Structural Defects Underlying Disorders with Neurological Involvement

Terzopoulos, G., Axarloglou, E., Sintou, E., Makridou, A., Gargani, S., Meditskou, S., Μanthou, M. E., Theotokis, P., & Dermitzakis, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198782

BindingDB Entry 50006664: Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.

BindingDB (2020) · UC San Diego · doi:10.7270/q21g0q81

Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy

Brunden, K. R., Zhang, B., Carroll, J., Yao, Y., Potuzak, J. S., Hogan, A.-M. L., Iba, M., James, M. J., Xie, S. X., Ballatore, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3059-10.2010 · Cited by 320

S5‐02‐01: Microtubule‐stabilizing drugs for abrogation and prevention of Alzheimer's disease

Trojanowski, J. Q. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.1948

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Trojanowski, J. Q. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-s1-o37 · Cited by 1

Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies

Brunden, K. R., Ballatore, C., Lee, V. M. ‐., Smith, A. B., & Trojanowski, J. Q. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120010 · Cited by 46

Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy

Makani, V. S., Zhang, B., Han, H., Yao, Y., Lassalas, P., Lou, K., Paterson, I., Lee, V. M. ‐., Trojanowski, J. Q., Ballatore, C., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0378-4 · Cited by 51